{"entity":{"id":"royal-marsden","kind":"institution","name":"The Royal Marsden","aka":[],"tldr":"The Royal Marsden was the world's first hospital dedicated to cancer (1851) and is paired with the Institute of Cancer Research.","summary":"The Royal Marsden in London was the world's first hospital dedicated to cancer, opened in 1851, and works as a pair with The Institute of Cancer Research; it ranks seventh in the Newsweek/Statista oncology list. Together they discovered abiraterone and worked out the clinical path for olaparib and PARP inhibition in BRCA-mutated cancers, with Johann de Bono and Andrew Tutt central, and the hospital leads the STAMPEDE prostate platform and breast trials while pioneering MR-linac adaptive radiotherapy. Nuclide links it to the KEYNOTE-048 head and neck paper, to prostate, mesothelioma, sarcoma and neuroendocrine tumour pages, and to bottlenecks about surgery and radiotherapy being under-funded relative to drugs. The question it keeps raising is how to fund trials of treatments no company owns. Stephen Johnston and James Larkin are among the people listed here.","asOf":"2026-09-04","links":[{"label":"Official website","url":"https://www.royalmarsden.nhs.uk"}],"tags":[],"related":[],"indications":[],"sections":[],"technologies":[],"targets":[],"drugs":["olaparib"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"city":"London","country":"GB","lat":51.49,"lng":-0.172,"institutionType":"cancer-center","website":"https://www.royalmarsden.nhs.uk","newsweekOncology2026":7,"programs":["Prostate cancer (abiraterone, PARP)","MR-linac","Breast cancer"]},"route":"/institutions/royal-marsden/","neighbours":{"drug":[{"id":"abiraterone","kind":"drug","name":"Abiraterone acetate","route":"/drugs/abiraterone/"},{"id":"olaparib","kind":"drug","name":"Olaparib","route":"/drugs/olaparib/"}],"indication":[{"id":"neuroendocrine","kind":"indication","name":"Neuroendocrine tumours","route":"/indications/neuroendocrine/"},{"id":"prostate","kind":"indication","name":"Prostate cancer","route":"/indications/prostate/"}],"trial":[{"id":"stampede","kind":"trial","name":"STAMPEDE","route":"/trials/stampede/"}],"person":[{"id":"chris-parker","kind":"person","name":"Chris C. Parker","route":"/people/chris-parker/"}]}}